About Us

Board of Directors

Our directors bring extensive expertise in corporate strategy, health care and venture capital, and have led or financed biopharma companies at all stages of development, from startup through commercialization. Their insights have been invaluable and will continue to guide Rodin through our next phases of growth.

Bruce Booth, D.Phil, Chairman Partner, Atlas Venture

Kees Been, MBA President & CEO, Lysosomal Therapeutics

John Creecy, M.S. CEO & Director, Remeditex Ventures

Jason Hong, Ph.D. Managing Director, Third Point LLC

Adam Rosenberg President & CEO, Rodin Therapeutics

Samantha Singer, M.S., MBA Entrepreneur in Residence, Third Rock Ventures

Clay Thorp, MPP Co-founder, Hatteras Venture Partners

Ben Robbins, M.D., MBA, Observer Venture Partner, GV